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Abstract

Here we report a hitherto unknown effect of a synthetic inactivation inhibitor on
inactivation in cardiac sodium channels (Navl.5) from two different species : human and bovine.
SDZ 211-93 9 stabilized the slow inactivated-state in both channels as seen by an increased
steady-state probability of slow inactivation. SDZ also destabilized the fast-inactivated state and
increased the amplitude of persistent currents. SDZ modulated conductance parameters , openstate fast inactivation time constants, and activation kinetics of hNavl.5, but not bNavl.5. These
findings will aid future studies designed to elucidate the binding site and molecular mechanisms
of inactivation inhibitors such as SDZ 211-939.
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1. Introduction

Cardiac voltage-gated sodium channels (Nav 1.5) are responsible for the influx of ionic
current that initiates myocardial action potentials. From the membrane resting potential,
depolarization causes the channel to go from a closed (deactivated) state to an open (activated)
state. Channels inactivate through two distinct mechanisms: fast and slow inactivation.
Membrane excitability, and therefore action potentials , is regulated by the likelihood of a
channel being in an inactivated state. The type of inactivation, fast or slow, differentially
regulates membrane excitability. Cellular modification of both types of inactivation allows
excitable membrane activity to be controlled. Such modification also suggests a convenient
method of pharmacological intervention in diseased and/or mutant cells.
The importance of properly functioning inactivation may be seen by the conditions
associated with abnormal inactivation activity. Fast [1,2] and slow inactivation [3] in Navl.5
have both been shown to cause life-threatening arrhytlunias such as Brugada syndrome and
chromosome 3-linked congenital long-QT syndrome. Another factor pointing to the importance
of slow inactivation regulation in Navl .5 is the drastic reduction of slow inactivation in cardiac
channels compared to skeletal channels . Approximately 20% of cardiac channels are slowinactivated in steady-state protocols [4] versus 80% in skeletal muscle channels [5]. If cardiac
channels were slow-inactivated to the same extent as in the skeletal muscle isoform, myocardial
tissue would quickly cease to conduct action potentials.
Fast inactivation occurs rapidly via structural components on the intracellular side of the
sodium channel [6], with onset and recovery time constants on the order of milliseconds . Slow
inactivation , however, has time constants on the order of seconds and is homologous with
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cumulative inactivation [7]. Whereas fast inactivation-kinetics allow membrane excitability to be
regulated over the course of an action potential, slow inactivation requires sustained or repeated
depolarizations for its effects to become physiologically relevant. Interestingly, the two states are
"reciprocally interactive" [8], the probability of one having an inverse relationship with that of
the other [6,9,10].
SDZ 211-939 (SDZ) belongs to a family of membrane permeable synthetic inactivation
inhibitors typified by DPI 201-106 (DPI) [11]. SDZ acts as a positive inotropic agent by
prolonging the open-state ofNavl.5 channels through inhibition of fast inactivation [12]. The
prolonged time spent in the open-state lengthens the duration of the action potential and
increases the intracellular Na + concentration. This lessens the concentration gradient driving the
Na +/Ca 2+-exchanger and results in a stronger force of contraction in myocardial tissue due to
increased intracellular Ca 2+-availability to contractile proteins [ 13]. Because of increased
contractility, DPI and other synthetic modifiers have been clinically studied to determine their
therapeutic usefulness in cases of cardiac failure [ 14, 15, 16].
Neither the binding site nor the mechanism of action for this family of compounds has been
identified. Researchers found [17], cloned, and characterized via heterologous expression [12] a
bovine cardiac sodium chmmel with drastically reduced sensitivity to DPI and its derivative
SDZ. The bovine cardiac channel (bNavl.5) is 92% homologous to the human cardiac channel
(hNav 1.5). Both the amount of similarity between the two channels and the unique effect of SDZ
on the bovine channel make these two channels well suited to studies seeking to determine the
mechanism and binding site of this family of inactivation inhibitors.
The main focus of our study was to ascertain the amount (if any) by which SDZ affects the
steady-state probability of slow inactivation in cardiac channels. Since the probability of a
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channel being in the slow-inactivated state is a determinant of myocardial excitability
modulation of slow inactivation presents a convenient way by which cell excitability may be
pharmacologically altered. In general, we sought in this study to characterize and compare the
effects of SDZ on hNavl.5 and bNavl.5 in an effort to better understand the structure/function
relationship ofNavl.5 .

2. Materials and Methods

2.1. Cell Culture

The cDNA for the ex-subunit of either hNav 1.5 or bNavl.5 (subcloned into pRc/CMV
vector, Invitrogen, Carlsbad, CA) was transfected into a human embryonic kidney cell line
(HEK293, ATCC number CRL-1573) using Polyfect Transfection Reagent (Qiagen , Valencia ,
CA). The cDNA for either the CD8 antigen or EGFP (subcloned into pEGFP-C 1vector ,
Clontech, Palo Alto , CA) was co-transfected in some experiments to aid with identification by
Dynabeads (M-450 CD8 , Dynal , Oslo , Norway) or fluorescence. 24-36 hours after transfection
and 24 hours before patch clamping , cells were plated onto glass cover slips. Cells were
maintained at 37°C in a humidified atmosphere with 5% CO 2 .

2.2. Electrophysiology

Sodium currents were recorded using the whole-cell patch clamp technique. All
recordings were done in a chamber containing (in mM): NaCl 140, KCl 4, CaCh 2, MgCh 1,
HEPES 10, pH 7.4. After fabrication (P-57, Sutter Instruments, Novato, CA), borosilicate patch
electrodes were coated with dental wax to reduce capacitance. Electrode resistance in the bath
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solution prior to attachment to the cell was between 1 and 3 MQ. Prior to recordings , the
electrodes were thermally polished and filled with (in mM) : CsCl 130, NaCl 10, EGTA 10, MgATP 4, Li-GTP 0.4, HEPES 10, pH 7.4. Temperature was maintained at 22± 0.2°C by a Peltier
device regulated by a temperature controller (HCC-1 00A, Dagan , Minneapolis , MN). Data were
obtained with an EPC-9 amplifier (HEKA, Lambrecht, Germany) and were software-low-passfiltered at 5 kHz. Sampling frequency was 50 kHz for slow inactivation protocols and 200 kHz
for all !I V protocols. Pulse software (HEKA) run on a 04 Macintosh was used to control both
voltage clamping and pulse protocols. After formation of a ~ l giga-Ohm seal , the seal was
allowed to stabilize for 30 s. A patch of membrane was excised via intra-electrode suction to
allow for who le-cell access. No recordings were done until peak current elicited by test pulses
remained steady (approximately two minutes) . Leak subtraction was performed automatically by
a p/4 procedure before each pulse protocol. Fast and series resistance were automatically
compensated such that series resistance was < 10 MQ . Holding potential was maintained at -100
mV between puls e protocols. Data sets with current rundown of greater than 10% were
discard ed.
Steady-state slow inactivation data were obtained from the following pulse protocol.
Membrane potential was held at-130 mV for 20 s to recover channels from previously induced
slow inactivation . A 60 s prepulse ranging from - 130 to - 10 mV was then delivered. Prepulse
potentials were alternated between high and low sweeps (- 130, -10, -120, -20, etc.) to avoid
accumulation of slow inactivation during the experiment. After the prepulse, the channels
recovered from fast inactivation during a 20 ms pulse at -130 m V before a test pulse of 20 ms at
- 10 mV.
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Conductance data were obtained as follows. Membrane potential was held at-13O mV
for 200 ms to insure that the channels were deactivated, stepped to a test pulse voltage (-90 to 40
mV in 10 mV increments) for 20 ms , and then returned to -130 mV for the next sweep. The test
pulse voltage was sufficiently long to observe activating and fast-inactivating sodium current.
After collection of control data, two mL of 2.5 or 25 µM SDZ (from where?, dissolved in
DMSO) were perfused into the recording chamber. SDZ data were not obtained during the two
minutes after perfusion, to allow for diffusion of SDZ and its association with the channels.

2. 3. Data Analysis

Data were analyzed in PulseFit (HEKA) and IgorPro (Wavemetrics, Lake Oswego , OR)
software . Steady-state slow inactivation curves were obtained from normalized data averaged
and fitted with the modified Boltzmann equation:

Illmax= (I1 - h) / [1 + exp(-zeo(Vm - Vi12))/(kT)] + h

(1)

where Imax is the maximum peak current measured , 11 and h are respectively the maximum and
minimum values fitted, z is the apparent valence (slope factor), e0 is the elementary charge , Vmis
the prepulse potential , Vi12is the midpoint potential , k is the Boltzmann constant, and Tis the
absolute temperature. The maximum probability of steady -state slow inactivation was reported as

1/lmaxat the most depolarized voltage of the curve and will be referred to as 'probability of slow
inactivation'.
Conductance data were obtained from 1/V curves using the equation:

G = fmaxf(Vm-Erev)

(2)
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where G is conductance,

Erev

is the reversal potential derived from minimizing error in G, and

other variables as stated above. Normalized conductance curves were then averaged and fitted
with the modified Boltzmann equation:

I I lmaz = 11/[l + exp(-zeo(Vm - Vi12))/(k1)]

(3)

where the variables are the same as those for equation 1 with the exception of Vmbeing the test
pulse potential.
Open-state fast inactivation time constants were obtained by fitting the current decay
portion of the 1/ V curves to the single exponential equation:
J(t) =Ip+ a1 exp(-t/'r)

(4)

where I(t) is current amplitude as a function oft (time), Ip is the plateau amplitude , a1 is the
amplitude at t = 0 (time of peak current) , and Tis the time constant.
lp1a1eau:lp eak
th

ratios were analyzed as follows:

6 order polynomial function.

/pl ateau

Ip eak

(peak current amplitude) was fit with a

(plateau current amplitude) was derived by fitting the

sustained current amplitude with a horizontal line . The sustained current amplitude was defined
by the current after 15-20 ms of the 20 ms test pulse; by 15 ms , current amplitudes in all
experiments had reached a plateau and remained steady to the end of the test pulse.
Ip1a1eau:lp eak

ratios and fast inactivation time constants were graphed using Excel

(Microsoft, Redmond , WA). All other graphs were made in Igor Pro.
All statistical values were obtained using the Student ' s t-test , or, when indicated by a
significant difference is standard deviations , Welch ' s alternate t-test using Instat software
(GraphPad Software , Inc., San Diego, CA). Two-tailed p-values are reported. Significant
difference was accepted at p<0.05. Statistical values are given as mean± standard error of the
mean (SEM). Throughout the text, n refers to the number of experiments.
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3. Results

3. I. SDZ affects plateau current in hNavf.5 and bNavf.5

The primary effect of synthetic inactivation inhibitors, such as SDZ appears to be to
destabilize the fast-inactivated state and thus create a plateau (or persistent) current. A greater
amount of destabilization results in an increased plateau current.
To determine the effect of SDZ on plateau (or persistent) current, we measured the
lp1a1eau:lp eak

ratio at the end of a depolarizing test pulse. A 20 ms test pulse to -10 mV elicited

currents after a conditioning pulse at - 130 mV for 200 ms. This protocol was sufficiently long to
display both peak and plateau currents.
As shown in Figure 1, hNavl.5 and bNavl.5 had similar

lplateau:lpeak

ratios in the absence

of SDZ (p< 0.57). Application of 2.5 µMand 25 µM SDZ resulted in a concentration-dependent
increase of lp1a1eau :lp eak ratios for both channel isoforms, although there was virtually no
difference in response to SDZ between the two isoforms .

3. 2. SDZ modulat es open-state fast inactivation time constants and activation kinetics of hNavl .5
but not bNaJ 5

Open-state fast inactivation time constants are illustrated in Figure 2 for voltages at
which large sodium currents were observed (-20 mV to 40 mV). Although SDZ affected bNavl.5
by either increasing (25 µM) or decreasing (2.5 µM) the time constants, the effect was not
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significant at either concentration. For hNavl.5, however, a significant increase was seen at the
voltages 0, 10, 20, and 30 m V following the perfusion of 25 µM SDZ.
Activation kinetics (data not shown) were obtained by measuring the current rise time
(defined as the rising portion of the current trace between 10% and 90% of the peak current
amplitude) during test pulses to -10 m V.
2.5 µM SDZ significantly decreased the activation time constants (dT) of hNavl.5 from
397 ± 26 µs (15) to 301 ± 22 µs (10) (p< 0.02). The application of 25 µM SDZ to hNavl.5
slightly increased dT to 435 ± 50 µs (15); however, the increase in dT was not statistically
significant (p< 0.51). The dT ofbNavl.5

followed the same trends as hNavl.5 in that 2.5 µM

SDZ decreased dT from 378 ± 26 µs (18) to 314 ± 40 µs (6) and 25 µM SDZ increased dT to 438
± 34 µs (6). These changes in dT were not statistically significant, (p <0.22 and 0.18 ,
respectively).

3. 3. SDZ differentially modulates conductance parameters

The most visible example of differential modulation by SDZ is seen by the effect of the
compound on the voltage-dependence

of the channels (see conductance curves in Figure 3). SDZ

caused large, significant shifts to more hyperpolarized potentials in hNavl.5, whereas such shifts
in activation voltage-dependence

were not seen for bNavl.5.

The midpoint potential (V 112) ofhNavl.5 was shifted-22.0

mV by 2.5 µM SDZ (p<

0.0001). No additional increase in this effect was seen at the higher concentration of SDZ (25
µM) where V 112was shifted-13.6 mV (p< 0.003). The effect on V 112 was not concentrationdependent in isoforms from both species as the effects on V 112 by the two concentrations were

9

not significantly different (p< 0.05 1). Additionally, the control V 1/2 measurements from each
isoform were very different with bNavl.5 having a V 112 28.9 mV more hyperpolarized than
hNavl .5.

3. 4. SDZ increases the steady-state probability of slow inactivation of hNavl. 5 and bNavl. 5

Previous studies using SDZ did not examine its effects on slow inactivation. Due to the
large effect of SDZ on fast inactivation [12] and the coupling between fast and slow inactivation
[5], we sought to determine the extent to which SDZ might affect the probability of slow
inactivation in Na vl.5. The channel isoforms hNavl.5 and bNavl.5 were used for two reasons.
First , slow inactivation parameters of hNav1.5 have been previously studied and abnormal slow
inactivation function implicated in several medical conditions [22,23]. Second , bNavl.5 has been
shown to be minimally affected by SDZ compared to this channel isoform in other species
[ 12, 17); differential effects betwe en the two isoforms might thus reve al important information
about the mechanisms and structur es underlyin g the effects of SDZ.
Figure 4 shows the steady-state slow inactivation curves for both channel types . The
maximum probability of slow inactivation for both hNavl.5 and bNa vl.5 was significantly
increased by application of 25 µM SDZ (p< 0.0003 and p < 0.04 , respectively). Data showing the
effect of SDZ on the midpoint (Vi 12) and the apparent valence (z) were also measured and are
summarized in Table 1. Interestingly, although SDZ affected the probability of slow inactivation ,
no significant effects were observed for Vi12, and the apparent valence was affected by SDZ only
in bNavl.5 (p< 0.0 1).

4. Discussion

Our data demonstrate that, besides the well-studied effect of synthetic modifiers such as
DPI on the stability of fast inactivation [18,19,20], one member of this class of drugs, SDZ, also
affects the stability and probability of slow inactivation. We have additionally shown that SDZ
differentially modulates the conductance parameters and open-state fast inactivation time
constants hNavl.5 and bNavl.5.
Single channel recordings show that fast-inactivated channels undergo "bursting" during
prolonged depolarizations. Bursting activity occurs when channels briefly recover from fast
inactivation, allowing conductance of sodium current as the channels are in the activated openstate, and then re-enter the fast-inactivated open-state [21]. The

/p 1ateau:/" eak

ratios we observed are

likely due to bursting channels . Bursting activity represents the relative stability of the fast
inactivated-state; bursting increases as the stability of the fast-inactivated state decreases .
Because our pulse protocols ensured nearly complete fast inactivation (verified by control data) ,
the SDZ-induced increase in /p 1ateau: /p eak ratio represents a decrease in stability of the fast
inactivated-state. For our control experiments , fplateau values are two orders of magnitude smaller
than I peak• With the addition of 25 µM SDZ, fp1at ea u values increased by an order of magnitude
compared to f peak•
Understanding SDZ modulation of slow inactivation is difficult since the underlying
mechanisms by which channels slow inactivate are poorly understood [22,23]. However, several
studies have shown an inverse relationship between the probabilities of fast and slow inactivation
[4,9 , 1O]. Given our results showing a decrease of fast inactivation stability and an increase of

11

slow inactivation stability, it appears that SDZ may exert its effects on the two types of
inactivation via their intrinsic coupling.
Previous studies have shown 1) that of swine, goat , and cattle, only cattle exhibited
reduced sensitivity to SDZ [17], and 2) that SDZ is markedly less effective in bNavl .5 compared
to rNavl.5 [12]. Based on these studies we hypothesized that the primary effect of SDZ,
inactivation inhibition, on hNavl.5 would be more similar to rNavl.5 than bNavl.5 (which had
been the only identified channel with reduced sensitivity to SDZ). Our plateau current results
show that SDZ destabilizes inactivation in hNavl.5 and bNavl.5 to the same extent and
contradict the hypothesis. However, Denae et al. (2002) expressed bNavl.5 and rNavl.5 in

Xenopus oocytes, whereas we expressed our channels in HEK293 cells. Different expression
systems have been shown to affect the biophysical properties of sodium channels and it is
possible that the inactivation destabilization effect of SDZ is altered by the expression system
[24].
The main area of structural difference between bNavl.5 and other chaimel-isoforms lies
in the cytoplasmic linker connecting domains II and III. Although the bovine and human
isoforms have DII-DIII linkers of the same length , the amount of conserved primary sequence in
only 82% in the DII-DIII linker compared with 92% for the entire sequence. Interestingly ,
mutations found in the human DII-DIII linker have effects similar to those of SDZ on persistent
currents although the wildtype sequence at these amino acids is conserved between the bovine
and human isoform. The polymorphism Sl 103Y has been correlated with an increased risk of
cardiac arrhythmias and was identified in 13.2% of African-Americans [25] and in a white
family [26]. A997S, associated with Sudden Infant Death Syndrome, also displays increased
fplateau

[27].
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The bovine amino acid residue corresponding to position 1103 in hNav 1.5 is conserved,
but the residue corresponding to position 997 in hNavl.5 is not conserved. The residue at this
position (1002) is serine, corresponding to the f plateau-alteringhuman polymorphism A997S.
However, this does not imply that a serine at the position universally increases lp1ateau
or is
involved in SDZ binding. In addition to demostrating similar

/p 1ateau:Jpeak

ratio responses to SDZ

characteristic of wildwhen compared with hNavl .5, bnavl .5 still displays the low level of I plateau
type cardiac channels and not the increased level observed for A997S [27]. Further studies are
needed to elucidate the role of that position on inactivation stability.
The mechanism by which SDZ affects sodium channels is unclear. Considering the
increased plateau current amplitudes in S 1103Y and A997S, and hNav 1.5 + SDZ compared to the
wild-type isoform, it appears that SDZ might destabilize fast inactivation by inducing a
conformational change. These factors also lead to the hypotheses that the DII-DIII linker is
involved in fast-inactivation stability, and that the linker may be the binding site for SDZ and
related compounds. Whether SDZ modulates slow inactivation directly or via a fast-slow
inactivation coupling remains to be determined. The DII-DIII linker has not, however, been
previously associated with the control of slow inactivation , suggesting an indirect effect of SDZ
on slow inactivation. Thus, the stabilization of slow inactivation, as suggested by the increase in
its maximum probability (Fig. 4), may be an indirect consequence of the destabilization of fast
inactivation , as suggested by the increase in time constants of hNavl.5 (Fig. 2) and the increase
in persistent current in both isoforms (Fig. 1).
In summary, we have shown that SDZ differentially affects hNavl.5 and bNavl.5, and
that an inactivation inhibitor not only modulated fast inactivation but also the probability of slow
inactivation. These results may serve as a basis for future studies aimed at elucidating the
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molecular mechanism of SDZ and the structure/function relationships of sodium channels.
Importantly, an understanding of the molecular mechanisms of both inactivation inhibitors and
sodium channel activity will aid the rational design of novel drugs for chronic cardiac failure, a
possibility that has not been adequately explored [16,12]. In light of recent studies showing the
expression of "neuronal" sodium channel isoforms in the heart [28,29], it will also be important
to study the effects of SDZ on these isoforms to gain a complete understanding of the
compound's effects on cardiac function.
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Table 1 Slow Inactivation, Conductance, and 1111a,eau:lp

eak

data
conductance

slow inactivation

channel
hNav1.5

SDZ
application
none (control)
2.5 µM SDZ
25 µM SDZ

bNav1.5

level(%)

apparentvalence(z)

70 ± 2 (8)

-2.5 + 0.2 (8)

-

-

none (control)

85 ± 2 (7)'
78 + 3 (5)

2.5 µM SDZ
25 µM SDZ

88±1(4)6

-

-2.5 ± 0.2 (7)
-3.6 ± 0.2 (5)'
-

-2.5 ± 0.2 (4)6

-----·--

Y,n (mV)
-80.9 ± 2.1 (8)
-

-77.4 ± 4.0 (7)
-9 LO± 4.7 (5)'
-

-83.9 ± 2.6 (4)

apparentvalence(z)

Y,n (mV)

33 ± 0.3 ( 15)
4.6 ± 0.5 (10)'
43 ± 0.5 (15)
3.5 ± 0.3 (18)
3.1±0.2(6)
4.5 ± 0.5 (9)

-18 .5 ± 2.0 (15)
-40.5 ± 1.8 ( 10)"
-32.1 ± 3.6 ( 15)"
-47.4 ±3. 1 ( 18)'
-503 ± 4.6 (6)
-48.2 ± 2.4 (9)

fplc11
ea11:fpeak

0.042 ±
0 120 ±
0.496 ±
0.034 ±
0.093 ±
0.449 ±

0.012
0.024
0.046
0.008
0.021
0.073

( 15)
(10)'
( 15)'
( 18)
(6)6
(9)6

All slow inactivation and conductance values were obtained from Boltzmann fits to individual data sets (as described in Materials
and Methods). Data are presented as means± SEM (n). •p < 0.05 versus hNav1.5 control. bP < 0.05 versus bNav 1.5 control.

Fig. 1. A. Sodium current traces showing the effect of SDZ on plateau current and an
illustration of the pulse protocol used to obtain
(presented in Table 1). B. Graph and table of

fp1ateau:lpeak

lp1ateau:lpeak

ratios and conductance data

ratios for hNavl.5 and bNavl.5

with and without SDZ. Obtained from the protocol described in Figure 2.

alp1a1eau:lp eak

ratios of hNavl.5 significantly increased with 2.5 and 25 µM SDZ (p< 0.004, 0.0001).
blp1ateau:lpeak

ratios of bNav 1.5 increased similarly upon application of 2.5 and 25 µM SDZ

(p< 0.004, 0.0005).

Fig. 2. The time constant of fast inactivation in hNav 1.5 is differentially affected by
SDZ. Panel A shows the time constants of fast inactivation, derived from an exponential
function fit to the decay of current during a test pulse to the voltages shown on the Xaxis , in hNav 1.5 in the absence (light gray circles) and presence of SDZ (2.5 µM; dark
gray triangles, and 25 ~tM; black squares) . Panel B shows the time constants of fast
inactivation in bNav 1.5 in the absence (light gray circles) and presence of SDZ (2.5 µM;
dark gray triangles , and 25 µM ; black squares) .

Fig. 3. A. Conductance curves (obtained from the protocol illustrated in Fig . 1) for
hNa vl.5 (light gray) , hNavl.5 + 2.5 µM SDZ (medium gray), and hNavl.5 + 25 µM SDZ
(black). B. Conductance curves for bNavl.5 (light gray), bNavl.5 + 2.5 µM SDZ
(medium gray), and bNavl.5 + 25 µM SDZ (black). Conductance curves shown above
were fitted with a modified Boltzmann equation (see Materials and Methods). aP < 0.05
versus hNavl .5 control midpoint. bp < 0.05 versus hNavl .5 apparent valence. No

significant differences were seen for SDZ-perfused bNavl.5 compared to bNavl .5
control.

Fig. 4. Average steady -state slow inactivation curves fitted with a modified Boltzmann

equation. A. Curves for hNavl.5 (light gray) and hNavl.5 + 25 µM SDZ (black). B.
Curves for bNavl.5 (light gray) and bNavl.5 + 25 µM SDZ (black). Inset shows pulse
protocol (see Materials and Methods for details). Data were not gathered for 2.5 µM
SDZ.
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